文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

COVID-19重症监护室死亡率的趋势:三次疫情高峰的启示

Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.
PubMed 文献 · Crit Care Med · 2022-01-01
一句话结论在2020年秋季和冬季(Lull 2和Surge 3)入住ICU的COVID-19患者死亡风险显著高于Surge 1,尽管经验增加且使用了循证治疗。

本研究为观察性队列研究,纳入2020年3月6日至2021年1月31日期间在亚特兰大四家学术医疗中心ICU治疗的1,686例成人COVID-19患者,比较不同时间段(Surge 1、Lull 1、Surge 2、Lull 2、Surge 3)的住院死亡率。总体死亡率为29.7%,各时段死亡率分别为28.7%、21.3%、25.2%、30.2%、34.7%(p=0.007)。调整基线和临床变量后,Lull 2和Surge 3的死亡风险显著高于Surge 1(RR分别为1.37和1.35)。死亡风险与年龄、合并症、器官衰竭评分、D-二聚体、CRP及ICU干预(机械通气、血管升压药、肾脏替代治疗、吸入血管扩张剂)相关。

要点

  • 在1,686例ICU的COVID-19患者中,总住院死亡率为29.7%,不同疫情时段死亡率显著不同(p=0.007)。
  • 与Surge 1相比,Lull 2(RR 1.37, 95%CI 1.03-1.81)和Surge 3(RR 1.35, 95%CI 1.04-1.77)的死亡风险显著增加。
  • 死亡风险与年龄较大、种族、民族、较低BMI、较高Elixhauser合并症指数、来自养老院、较高SOFA评分、较高D-二聚体和CRP、以及接受机械通气、血管升压药、肾脏替代治疗或吸入血管扩张剂相关。
  • 尽管经验和循证治疗增加,2020年秋冬季节ICU的COVID-19患者死亡风险最高,原因尚不明确。
  • 该研究为观察性设计,不能推断因果关系。

适用人群与场景

  • ≥18岁成人COVID-19患者,在研究期间(2020年3月6日至2021年1月31日)入住ICU。
  • 排除标准原文未提及。
  • 场景为四家学术医疗中心网络的ICU。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:观察性队列研究,样本量1,686例,四家医院。
  • 主要终点:住院死亡率,总体29.7%,各时段分别为28.7%、21.3%、25.2%、30.2%、34.7%(p=0.007)。
  • 调整后风险:与Surge 1相比,Lull 2的RR 1.37(95%CI 1.03-1.81),Surge 3的RR 1.35(95%CI 1.04-1.77)。
  • 关键次要终点:原文未提及。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:观察性队列研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:单中心网络(四家医院),观察性设计,不能推断因果关系;原因不明。

对床旁实践的改变

  • 应认识到2020年秋冬季节ICU的COVID-19患者死亡风险较高,但研究不能改变具体治疗;需关注高危因素如年龄、合并症、器官衰竭和特定干预。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019.

DESIGN: Observational cohort study from March 6, 2020, to January 31, 2021.

SETTING: ICUs at four hospitals within an academic health center network in Atlanta, GA.

PATIENTS: Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: September to November, Surge 3: December to January).

MEASUREMENTS AND MAIN RESULTS: Among 1,686 patients with coronavirus disease 2019 admitted to an ICU during the study period, all-cause hospital mortality was 29.7%. Mortality differed significantly over time: 28.7% in Surge 1, 21.3% in Lull 1, 25.2% in Surge 2, 30.2% in Lull 2, 34.7% in Surge 3 (p = 0.007). Mortality was significantly associated with 1) preexisting risk factors (older age, race, ethnicity, lower body mass index, higher Elixhauser Comorbidity Index, admission from a nursing home); 2) clinical status at ICU admission (higher Sequential Organ Failure Assessment score, higher d-dimer, higher C-reactive protein); and 3) ICU interventions (receipt of mechanical ventilation, vasopressors, renal replacement therapy, inhaled vasodilators). After adjusting for baseline and clinical variables, there was a significantly increased risk of mortality associated with admission during Lull 2 (relative risk, 1.37 [95% CI = 1.03-1.81]) and Surge 3 (relative risk, 1.35 [95% CI = 1.04-1.77]) as compared to Surge 1.

CONCLUSIONS: Despite increased experience and evidence-based treatments, the risk of death for patients admitted to the ICU with coronavirus disease 2019 was highest during the fall and winter of 2020. Reasons for this increased mortality are not clear.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Auld SC, Harrington KRV, Adelman MW, et al. Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges. Crit Care Med. 2022. PMID: 34259667. doi:10.1097/CCM.0000000000005185

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。